Synthetic approaches and biological activities of 4-hydroxycoumarin derivatives

Molecules

Volumn 14, Issue 11, 2009, Pages 4790-4803

  Jung, Jae Chul ^a   Park, Oee Sook ^b  

^a Ewha Womans University School of Medicine   (South Korea)

^b Chungbuk National University   (South Korea)

Author keywords

4 hydroxycoumarin; Anticoagulant; Coupling reaction; Ring cyclization; Rodenticide; Tetralone

Indexed keywords

EID: 73349085571     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14114790     Document Type: Review

References (49)

1. Adami, E.; Marazzi-Uberti, E.; Turba, C. Analgesic action of 4-hydroxycoumarin. Arch. Ital. Sci. Farmacol. 1959, 9, 61-69.
2. Chiarino, D.; Grancini, G. C.; Frigeni, V.; Carenzi, A. Preparation and formulation of 4-(3-coumarinyl) thiazole derivatives with antiallergic, antianaphylactic and antiarthritic activity. Eur. Pat. Appl. EP 284017, 1988.
3. Luchini, A. C.; Rodrigues-Orsi, P.; Cestari, S. H.; Seito, L. N.; Witaicenis, A.; Pellizzon, C. H.; Stasi, L. C. D. Intestinal anti-inflammatory activity of coumarin and 4-hydroxycoumarin in the trinitrobenzenesulphonic acid model of rat colitis. Biol. Pharm. Bull. 2008, 31, 1343-1350.
4. Stern, P.; Dezelic, M.; Kosak, R. Analgetic and antipyretic action of vitamin K and dicoumarol with special consideration of 4-hydroxycoumarin. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 1957, 232, 356-359.
5. Chohan, Z. H.; Shaikh, A. U.; Rauf, A.; Supuran, C. T. Antibacterial, antifungal and cytotoxic properties of novel N-substituted sulfonamides from 4-hydroxycoumarin. J. Enz. Inhib. Med. Chem. 2006, 21, 741-748.
6. Kirkiacharian, B. S.; Clercq, E.; Kurkjian, R.; Pannecouque, C. New synthesis and anti-HIV and antiviral properties of 3-arylsulfonyl derivatives of 4-hydroxycoumarin and 4-hydroxyquinolone. J. Pharm. Chem. 2008, 42, 265-270.
7. Velasco-Velázquez, M. A.; Agramonte-Hevia, J.; Barrera, D.; Jiménez-Orozco, A.; García-Mondragón, M. J.; Mendoza-Patiño, N.; Landa, A.; Mandoki, J. 4-Hydroxycoumarin disorganizes the actin cytoskeleton in B16-F10 melanoma cells but not in B82 fibroblasts, decreasing their adhesion to extracellular matrix proteins and motility. Cancer Lett. 2003, 198, 179-186.
8. Shapiro, S.; Sherwin, B. Thromboembolization. II. The use of dicumarol (3, 3'-methylenebis (4-hydroxycoumarin) in embolization. Report of five cases. N. Y. State J. Med. 1943, 43, 45-52.
9. Butsch, W. L.; Stewart, J. D. Administration of dicoumarin compound for prophylaxis of postoperative thrombosis and embolism. Arch. Surg. 1942, 45, 551-553.
10. Hintz K. K; Ren J. Tetramethylpyrazine elicits disparate responses in cardiac contraction and intracellular Ca (2+) transients in isolated adult rat ventricular myocytes. Vascul. Pharmacol. 2003, 40, 213-217.
11. Manolov, I.; Maichle-Moessmer, C.; Danchev, N. Synthesis, structure, toxicological and pharmacological investigations of 4-hydroxycoumarin derivatives. Eur. J. Med. Chem. 2006, 41, 882-890.
12. Samama, M. M. A century of progress. From biology to antithrombotic agents. J. Mal. Vasc. 2001, 26, 165-168.
13. Bulut, M.; Erk, C. Improved synthesis of some hydroxycoumarins. Dyes Pigments 1996, 30, 99-104.
14. Kang, H.; Kwon, K. S.; Kang, D.; Lee, J. C. Enhanced, perpendicular liquid-crystal alignment on rubbed films of a coumarin-containing polystyrene. Macromol. Chem. Phys. 2007, 208, 1853-1861.
15. Au, N.; Rettie, A. E. Pharmacogenomics of 4-hydroxycoumarin anticoagulants. Drug Metab. Rev. 2008, 40, 355-375.
16. Hamdi, N.; Saoud, M.; Romerosa, A. 4-Hydroxy Coumarine: A versatile reagent for the synthesis of heterocyclic and vanillin ether coumarins with biological activities. Top. Heterocycl. Chem. 2007, 11, 283-301.
17. Hamdi, N.; Saoud, M.; Romerosa, A.; Hassen R. B. Synthesis, spectroscopic and antibacterial investigations of new hydroxy ethers and heterocyclic coumarin derivatives. J. Heterocycl. Chem. 2008, 45, 1835-1841.
18. Park, O. S.; Jang, B. S. Synthesis of 4-hydroxycoumarin derivatives-1: An efficient synthesis of flocoumafen. Arch. Pharm. Res. 1995, 18, 277-281.
19. Jung, J. C; Lee, J. H.; Oh, S.; Lee, J. G.; Park, O. S. Synthesis and antitumor activity of 4-hydroxycoumarin derivatives. Bioorg. Med. Chem. Lett. 2004, 14, 5527-5531.
20. Van Heerden, P. S.; Bezuidenhoudt, B. C. B.; Ferreira, D. Improved synthesis of the rodenticides diphenacoum and brodifacoum. J. Chem. Soc. Perkin Trans. 1 1997, 8, 1141-1146.
21. Chen, D. U.; Kuo, P. Y.; Yang, D. Y. Design and synthesis of novel diphenacoum-derived, conformation-restricted vitamin K 2, 3-epoxide reductase inhibitors. Bioorg. Med. Chem. Lett. 2005, 15, 2665-2668.
22. Manolov, I.; Danchev, N. D. Synthesis, toxicological, and pharmacological assessment of some oximes and aldehyde condensation products of 4-hydroxycoumarin. Arch. Pharm. Pharm. Med. Chem. 1999, 332, 243-248.
23. Hamdi, N.; Puerta, M. C.; Valerga, P. Synthesis, structure, antimicrobial and antioxidant investigations of dicoumarol and related compounds. Euro. J. Med. Chem. 2008, 43, 2541-2548.
24. Shanmugasundaram, M.; Manikandan, S.; Raghunathan, R. High chemoselectivity in microwave accelerated intramolecular domino Knoevenagel hetero Diels-Alder reactions-an efficient synthesis of pyrano[3-2c]coumarin frameworks. Tetrahedron 2002, 58, 997-1003.
25. Dezelic, M.; Trkovnik, M. Syntheses of some 4-hydroxycoumarins and their condensation products with aldehydes and carboxylic acids. Anticoagulant activity of some 4-hydroxycoumarin derivatives. J. Med. Chem. 1964, 7, 284-288.
26. Pauly, H.; Lockemann, K. Methods of formation of monophenol ketones and a new synthesis of benzotetronic acid. Ber. Dtsch. Chem. Ges. 1915, 48, 28-32.
27. Myszka, D. G.; Swenson, R. P. Synthesis of the photoaffinity probe 3-(p-azidobenzyl)-4-hydroxycoumarin and identification of the dicoumarol binding site in rat liver NAD (P) H: Quinone reductase (EC 1.6.99.2). J. Biol. Chem. 1991, 266, 4789-4797.
28. Almeda, S.; Bing, D. H.; Laura, R.; Friedman, P. A. Photoaffinity inhibition of rat liver NAD (P) H dehydrogenase by 3-(α-acetonyl-p- azidobenzyl)-4-hydroxycoumarin. Biochemistry 1981, 20, 3731-3737.
29. Obach, R. S.; Spink, D. C.; Chen, N.; Kaminsky, L. S. Azidowarfarin photoaffinity probes of purified rat liver cytochrome P4501A1. Arch. Biochem. Bioph. 1992, 294, 215-222.
30. Van Heerden, P. S.; Bezuidenhoudt, B. C. B.; Ferreira, D. Efficient asymmetric synthesis of the four diastereomers of diphenacoum and brodifacoum. Tetrahedron 1997, 53, 6045-6056.
31. Halland, N.; Hansen, T.; Jorgensen, K. A. Organocatalytic asymmetric Michael reaction of cyclic 1, 3-dicarbonyl compounds and α, β-unsaturated ketones-A highly atom-economic catalytic onestep formation of optically active warfarin anticoagulant. Angew. Chem. Int. Ed. 2003, 42, 4955-4957.
32. Cravotto, G.; Nano, G. M.; Palmisano, G.; Tagliapietra, S. An asymmetric approach to coumarin anticoagulants via hetero-Diels-Alder cycloaddition. Tetrahedron Asymmetry 2001, 12, 707-709.
33. Thumboo, J.; O'Duffy, J. D. A prospective study of the safety of joint and soft tissue aspirations and injections in patients taking warfarin sodium. Arthritis Rheum. 1998, 41, 736-739.
34. Eichbaum, F. W.; Slemer, O.; Zyngier, S. B. Antiinflammatory effect of warfarin and vitamin K1. Naunyn Schmiedeberg Arch. Pharmacol. 1979, 307, 185-190.
35. Colucci, M.; Delaini, F.; De Bellis Vitti, G.; Locati, D.; Poggi, A.; Semeraro, N.; Donati, M. B. Cancer cell procoagulant activity, Warfarin and experimental metastases. Dev. Oncol. 1980, 4, 90-94.
36. Sutcliffe, F. A.; MacNicoll, A. D.; Gibson, G. G. Aspects of anticoagulant action: A review of the pharmacology, metabolism and toxicology of warfarin and congeners. Rev. Drug Metab. Drug Interact. 1987, 5, 225-272.
37. Wessler, S.; Gitel, S. N.; Bank, H.; Martinowitz, U.; Stephenson, R. C. An assay of the antithrombotic action of warfarin: Its correlation with the inhibition of stasis thrombosis in rabbits. Thromb. Haemost. 1979, 40, 486-498.
38. Marchini, S.; Turillazzi, P. G. Effect of an anticoagulant rodenticide on the female albino rat with offspring. Parassitologia 1978, 20, 59-70.
39. Saxena, Y.; Bhasin, H. Novel second generation anticoagulants against field rodents. Natl. Acad. Sci. Lett. 1991, 14, 483-485.
40. Khalifa, B. A. A.; Salem, F. M. S.; Menha, M. A. Embryotoxic and teratogenic effects of flocoumafen in chick embryos and white rats. J. Appl. Anim. Res. 1992, 2, 81-85.
41. Chaudhary, V.; Tripathi, R. S. Evaluation of single dose efficacy of difethialone - a secondgeneration anticoagulant for the control of rodents inhabiting arid ecosystem. Indian J. Agr. Sci. 2006, 76, 736-739.
42. Shore, R. F.; Birks, J. D. S.; Afsar, A.; Wienburg, C. L.; Kitchener, A. C. Spatial and temporal analysis of second-generation anticoagulant rodenticide residues in polecats (Mustela putorius) from throughout their range in Britain, 1992-1999. Environ. Pollut. 2003, 122, 183-193.
43. Zurawski, J. M.; Kelly, E. A. Pregnancy outcome after maternal poisoning with brodifacoum, a long-acting warfarin-like rodenticide. Obstet. Gynecol. 1997, 90, 672-674.
44. Hadler, M. R.; Shadbolt, R. S. Novel 4-hydroxycoumarin anticoagulants active against resistant rats. Nature 1975, 253, 275-277.
45. Beier, A. P.; Popov, V. A.; Efremenko, V. I. The effect of anticoagulants on the transmission of plague causative agent. Med. Parazitol (Mosk) 1999, 2, 40-43.
46. Myszka, D. G.; Swenson, R. P. Synthesis of 3-(4-azido-5-iodosalicylamido) -4-hydroxycoumarin: Photoaffinity labeling of rat liver dicoumarol-sensitive NAD (P) H: Quinone reductase. Biochem. Bioph. Res. Commun. 1990, 172, 415-422.
47. Rehman, A. B.; Ahmad, S. I. Studies on warfarin, coumatetralyl and difenacoum as anticoagulant agents. J. Pharm. 1982, 1, 1-13.
48. Vandenbroucke, V.; Bousquet-Melou, A.; De Backer, P.; Croubels, S. Pharmacokinetics of eight anticoagulant rodenticides in mice affer single oral administration. J. Vet. Pharmacol. Ther. 2008, 31, 437-445.
49. Manolov, I.; Danchev, N. D. Synthesis, toxicological and pharmacological assessment of some 4-hydroxycoumarin derivatives. Eur. J. Med. Chem. 1995, 30, 531-535. © 2009.